Creative Planning
GSK icon

Creative Planning’s GSK GSK Stock Holding History

Creative Planning’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.6M Buy
427,414
+45,772
+12% +$2.48M 0.02% 374
2025
Q4 		$18.7M Buy
381,642
+48,306
+14% +$2.25M 0.01% 406
2025
Q3 		$14.4M Buy
333,336
+37,980
+13% +$1.48M 0.01% 449
2025
Q2 		$11.3M Buy
295,356
+7,086
+2% +$271K 0.01% 483
2025
Q1 		$11.2M Buy
288,270
+54,209
+23% +$1.98M 0.01% 452
2024
Q4 		$7.92M Buy
234,061
+22,961
+11% +$827K 0.01% 529
2024
Q3 		$8.63M Buy
211,100
+7,854
+4% +$321K 0.01% 478
2024
Q2 		$7.82M Buy
203,246
+9,322
+5% +$392K 0.01% 483
2024
Q1 		$8.31M Buy
193,924
+6,448
+3% +$266K 0.01% 457
2023
Q4 		$6.95M Sell
187,476
-12,583
-6% -$452K 0.01% 476
2023
Q3 		$7.25M Buy
200,059
+35,231
+21% +$1.25M 0.01% 432
2023
Q2 		$5.87M Sell
164,828
-10,845
-6% -$389K 0.01% 477
2023
Q1 		$6.25M Buy
175,673
+15,038
+9% +$526K 0.01% 445
2022
Q4 		$5.64M Buy
160,635
+4,716
+3% +$157K 0.01% 454
2022
Q3 		$4.59M Buy
155,919
+2,833
+2% +$107K 0.01% 462
2022
Q2 		$8.33M Buy
153,086
+62,088
+68% +$3.43M 0.01% 355
2022
Q1 		$4.96M Sell
90,998
-5,258
-5% -$286K 0.01% 457
2021
Q4 		$5.31M Buy
96,256
+2,567
+3% +$134K 0.01% 405
2021
Q3 		$4.47M Buy
93,689
+7,431
+9% +$373K 0.01% 441
2021
Q2 		$4.29M Sell
86,258
-7,369
-8% -$354K 0.01% 449
2021
Q1 		$4.18M Buy
93,627
+12,670
+16% +$575K 0.01% 459
2020
Q4 		$3.72M Sell
80,957
-1,850
-2% -$85K 0.01% 449
2020
Q3 		$3.9M Sell
82,807
-386
-0.5% -$19.3K 0.01% 362
2020
Q2 		$4.24M Buy
83,193
+2,537
+3% +$130K 0.01% 312
2020
Q1 		$3.82M Sell
80,656
-19,426
-19% -$1.04M 0.01% 292
2019
Q4 		$5.88M Buy
100,082
+3,728
+4% +$207K 0.02% 267
2019
Q3 		$5.14M Sell
96,354
-13,736
-12% -$707K 0.02% 279
2019
Q2 		$5.51M Buy
110,090
+229
+0.2% +$11.5K 0.02% 268
2019
Q1 		$5.74M Sell
109,861
-770
-0.7% -$38.5K 0.02% 250
2018
Q4 		$5.28M Sell
110,631
-10,108
-8% -$498K 0.02% 237
2018
Q3 		$6.06M Buy
120,739
+42,518
+54% +$2.16M 0.02% 238
2018
Q2 		$3.94M Sell
78,221
-1,004
-1% -$50.6K 0.02% 312
2018
Q1 		$3.87M Sell
79,225
-314
-0.4% -$14.6K 0.02% 308
2017
Q4 		$3.53M Sell
79,539
-1,106
-1% -$51.1K 0.02% 318
2017
Q3 		$4.09M Sell
80,645
-6,373
-7% -$323K 0.02% 275
2017
Q2 		$4.69M Buy
87,018
+2,739
+3% +$146K 0.02% 228
2017
Q1 		$4.44M Sell
84,279
-4,616
-5% -$234K 0.02% 226
2016
Q4 		$4.28M Sell
88,895
-5,235
-6% -$259K 0.03% 232
2016
Q3 		$5.08M Buy
94,130
+14,181
+18% +$778K 0.03% 194
2016
Q2 		$4.33M Sell
79,949
-1,013
-1% -$53.4K 0.03% 187
2016
Q1 		$4.1M Sell
80,962
-4,506
-5% -$224K 0.03% 179
2015
Q4 		$4.31M Sell
85,468
-1,427
-2% -$72.7K 0.04% 182
2015
Q3 		$4.18M Sell
86,895
-1,344
-2% -$70K 0.04% 176
2015
Q2 		$4.59M Buy
88,239
+4,898
+6% +$276K 0.04% 156
2015
Q1 		$4.81M Buy
83,341
+32,316
+63% +$1.85M 0.05% 151
2014
Q4 		$2.73M Buy
51,025
+10,088
+25% +$564K 0.03% 212
2014
Q3 		$2.35M Buy
40,937
+8,605
+27% +$528K 0.03% 212
2014
Q2 		$2.16M Sell
32,332
-2,488
-7% -$168K 0.03% 214
2014
Q1 		$2.33M Sell
34,820
-5,214
-13% -$352K 0.04% 176
2013
Q4 		$2.67M Buy
40,034
+3,601
+10% +$233K 0.05% 148
2013
Q3 		$2.29M Sell
36,433
-4,637
-11% -$298K 0.05% 135
2013
Q2 		$2.56M Buy
+41,070
New +$2.61M 0.06% 107

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Creative Planning's GSK Position: Q1 2026 in Review

Creative Planning increased its GSK (GSK) stake by 12% in Q1 2026, buying an estimated $2.48M and bringing the position to 427,414 shares worth $23.6M. The position accounts for 0.02% of the portfolio, ranked #374.

Creative Planning first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Creative Planning held 427,414 shares of GSK worth $23.6M as of Q1 2026.
  • Creative Planning bought 45,772 GSK shares in Q1 2026, an estimated $2.48M.
  • GSK made up 0.02% of Creative Planning's portfolio in Q1 2026, its #374 holding.
  • Creative Planning first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.